Retrospective study finds that cancer drug Dasatinib also lowers blood glucose

Dasatinib is increasingly used as a senolytic in addition to its history as a cancer drug.

Full Paper Here: Antidiabetic Effects of the Senolytic Agent Dasatinib

Currently being tested as therapy for Alzheimers:

Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice